Veregen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2018
012320082018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • You-Ping Zhu
  • Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
  • 2017
This paper introduces regulatory pathways and characteristic quality requirements for marketing authorization of herbal medicinal… (More)
Is this relevant?
2016
2016
Throughout most of history medicinal plants (and their bioactive principles) have long had a central role in the treatment of a… (More)
Is this relevant?
Review
2014
Review
2014
In 2012, USA Food and Drug Administration (FDA) approved 39 new drugs, however, there are only two botanical drugs (one topical… (More)
Is this relevant?
Review
2014
Review
2014
External genital and perianal warts (EGW)—the most common viral sexually transmitted disease in the United States—are caused by… (More)
  • table 1
Is this relevant?
Review
2012
Review
2012
Many botanical products are used widely in the United States. Depending on its labeling and intended use, a botanical product can… (More)
Is this relevant?
2010
2010
  • Fanghua Huang
  • Zhongguo Zhong yao za zhi = Zhongguo zhongyao…
  • 2010
Pharmacokinetics study is one of main components of pharmaceuticals development. Food and Drug Administration (FDA) approved… (More)
Is this relevant?
Review
2010
Review
2010
OBJECTIVE To evaluate the cost-effectiveness and treatment-cost impact of sinecatechins (Veregen) as first-line therapy against… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
FDA approved the first botanical drug of non-simplex ingredient on 31st Oct 2006. The new drug's trade name is Veregen 15… (More)
Is this relevant?
Review
2008
Review
2008
Toxicological studies constitute an essential part of the effort in developing an herbal medicine into a drug product. The US… (More)
Is this relevant?